$VDRM if you're Johnson and Johnson and Neosporin is one of your products wouldn't you want to acquire Vitastem if it appears to be a superior product? The reviews on Amazon are excellent! This is a very solid and undervalued company either way. What are some realistic price targets for 2021 and 2022 if things progress as expected and they get more deals done, financials completed, and uplist. My money is in $ENZC right now. I'm hoping to get up to 10,000,000 shares here if that one ever moves. I feel like $.50 is a completely fair target! I like this one more each day!